|
CA2442282A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Cellect Technologies Corp. |
Methods devices and systems for sorting and separating particles
|
|
US7888060B2
(en)
*
|
2001-03-30 |
2011-02-15 |
Nanoprobes, Inc. |
Method for detecting a target using enzyme directed deposition of elemental metal
|
|
US7691598B2
(en)
*
|
2001-03-30 |
2010-04-06 |
Nanoprobes, Inc. |
Method for detecting a target molecule by metal deposition
|
|
US7642064B2
(en)
|
2003-06-24 |
2010-01-05 |
Ventana Medical Systems, Inc. |
Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
|
|
CA2609702C
(en)
|
2005-04-28 |
2013-05-28 |
Ventana Medical Systems, Inc. |
Antibody conjugates via heterobifunctional peg linkers
|
|
US20070117153A1
(en)
|
2005-11-23 |
2007-05-24 |
Christopher Bieniarz |
Molecular conjugate
|
|
DK2444807T3
(da)
|
2006-11-01 |
2014-08-11 |
Ventana Med Syst Inc |
Mono- og dinitropyrazolhaptenkonjugater
|
|
JP4920553B2
(ja)
*
|
2006-11-08 |
2012-04-18 |
富士フイルム株式会社 |
イムノクロマトグラフキット
|
|
EP2167963B1
(de)
|
2007-05-23 |
2019-04-17 |
Ventana Medical Systems, Inc. |
Polymerträger für immunohistochemie und in situ hybridisierung
|
|
FR2924601A1
(fr)
*
|
2007-12-07 |
2009-06-12 |
Oreal |
Composes diphosphate d'hydroquinone et leur utilisation pour depigmenter la peau.
|
|
WO2009149013A2
(en)
|
2008-06-05 |
2009-12-10 |
Ventana Medical Systems, Inc. |
Compositions comprising nanomaterials and method for using such compositions for histochemical processes
|
|
EP2334827B1
(de)
|
2008-08-22 |
2015-03-11 |
Ventana Medical Systems, Inc. |
Verfahren zum chromogenen nachweis von zwei oder mehr zielmolekülen in einer einzelprobe
|
|
KR101027036B1
(ko)
*
|
2009-05-28 |
2011-04-11 |
주식회사 인포피아 |
금 이온의 환원에 의한 측방유동 분석에서의 신호 증폭 방법 및 이를 이용한 측방유동 분석 디바이스
|
|
CA2780827A1
(en)
|
2009-12-31 |
2011-07-07 |
Ventana Medical Systems, Inc. |
Methods for producing uniquely specific nucleic acid probes
|
|
EP2539355B1
(de)
|
2010-02-26 |
2016-10-05 |
Ventana Medical Systems, Inc. |
In-situ hybridisierung mit polytag-sonden
|
|
AU2011248607B2
(en)
|
2010-04-27 |
2015-02-05 |
Ventana Medical Systems, Inc. |
Antibody-nanoparticle conjugates and methods for making and using such conjugates
|
|
ES2676183T3
(es)
|
2010-07-02 |
2018-07-17 |
Ventana Medical Systems, Inc. |
Detección de dianas usando marcas de masa y espectrometría de masas
|
|
US9103762B2
(en)
|
2010-10-28 |
2015-08-11 |
Eth Zurich |
Method for electrical detection of biomolecules by metal dissolution and Assay kit therefore
|
|
SG190892A1
(en)
|
2010-12-30 |
2013-07-31 |
Ventana Med Syst Inc |
Enhanced deposition of chromogens utilizing pyrimidine analogs
|
|
US8703439B1
(en)
|
2011-01-31 |
2014-04-22 |
Linda Lester |
Point of care iodine sensor
|
|
US9562259B2
(en)
|
2011-03-14 |
2017-02-07 |
Ventana Medical Systems, Inc. |
Method of analyzing chromosomal inversions
|
|
ES2597032T3
(es)
|
2011-05-04 |
2017-01-13 |
HTG Molecular Diagnostics, Inc |
Mejoras en un ensayo cuantitativo de protección contra la nucleasa (qNPA) y secuenciación (qNPS)
|
|
WO2013167387A1
(en)
|
2012-05-10 |
2013-11-14 |
Ventana Medical Systems, Inc. |
Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
|
|
EP2872646B1
(de)
|
2012-07-12 |
2017-08-30 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Verfahren zur vorhersage der überlebenszeit und behandlungsreaktion eines patienten mit einem soliden tumor mit einer signatur aus 21 genen
|
|
WO2014048942A1
(en)
|
2012-09-25 |
2014-04-03 |
Ventana Medical Systems, Inc. |
Probes for pten, pik3ca, met, and top2a, and method for using the probes
|
|
US9938523B2
(en)
*
|
2013-03-15 |
2018-04-10 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
|
|
WO2015036405A1
(en)
|
2013-09-10 |
2015-03-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating basal cell carcinoma
|
|
WO2015069787A1
(en)
|
2013-11-05 |
2015-05-14 |
Htg Molecular Diagnostics, Inc. |
Methods for detecting nucleic acids
|
|
EP3110966A1
(de)
|
2014-02-24 |
2017-01-04 |
Ventana Medical Systems, Inc. |
Automatisierter rna-nachweis mit markierten 2'-o-methyl-rns-oligonukleotidsonden und signalverstärkungssystemen
|
|
EP3152577B1
(de)
|
2014-06-06 |
2018-07-18 |
Ventana Medical Systems, Inc. |
Bedeutung der intratumoralen her2 heterogenität in brustkrebs und deren verwendung
|
|
CA2957783C
(en)
|
2014-10-02 |
2023-02-28 |
Ventana Medical Systems, Inc. |
Polymers and conjugates comprising the same
|
|
EP3009147A1
(de)
|
2014-10-16 |
2016-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Behandlung von resistenten Glioblastomen
|
|
ES2791950T3
(es)
|
2015-02-03 |
2020-11-06 |
Ventana Med Syst Inc |
Ensayo histoquímico para evaluar la expresión del ligando de muerte programada 1 (PD-L1)
|
|
AU2016232223A1
(en)
|
2015-03-16 |
2017-08-31 |
University Of Washington |
Materials and methods for detecting androgen receptor splice variants and uses thereof
|
|
AU2016249839B2
(en)
|
2015-04-17 |
2021-09-09 |
Ventana Medical Systems, Inc. |
Antibodies, compositions, and immunohistochemistry methods for detecting C4.4a
|
|
WO2016189065A1
(en)
|
2015-05-26 |
2016-12-01 |
Ventana Medical Systems, Inc. |
Method and system for assessing stain quality for in-situ hybridization and immunohistochemistry
|
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
|
WO2017055325A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of nk cells in a tissue sample
|
|
WO2017055326A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
|
WO2017055324A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cells of monocytic origin in a tissue sample
|
|
WO2017055320A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cytotoxic lymphocytes in a tissue sample
|
|
WO2017055319A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of b cells in a tissue sample
|
|
WO2017055322A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of neutrophils in a tissue sample
|
|
WO2017055321A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of fibroblasts in a tissue sample
|
|
WO2017055327A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of endothelial cells in a tissue sample
|
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
|
WO2017067944A1
(en)
|
2015-10-19 |
2017-04-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from triple negative breast cancer
|
|
WO2017132276A1
(en)
|
2016-01-26 |
2017-08-03 |
Ventana Medical Systems, Inc. |
Predictive diagnostic workflow for tumors usnig automated dissection, next generation sequencing, and automated slide stainers
|
|
WO2017155996A1
(en)
|
2016-03-08 |
2017-09-14 |
Ventana Medical Systems, Inc. |
Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
|
|
WO2017182834A1
(en)
|
2016-04-19 |
2017-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating resistant glioblastoma
|
|
WO2017202962A1
(en)
|
2016-05-24 |
2017-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
|
WO2018011107A1
(en)
|
2016-07-11 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of er-alpha 46 in methods and kits for assessing the status of breast cancer
|
|
WO2018011166A2
(en)
|
2016-07-12 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
|
WO2018046736A1
(en)
|
2016-09-12 |
2018-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from cancer
|
|
WO2018055080A1
(en)
|
2016-09-22 |
2018-03-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
|
|
EP3516397A1
(de)
|
2016-09-23 |
2019-07-31 |
Ventana Medical Systems, Inc. |
Verfahren und systeme zur bewertung extrazellulärer matrixbiomarker in tumorproben
|
|
WO2018091419A1
(en)
|
2016-11-15 |
2018-05-24 |
Ventana Medical Systems, Inc. |
Compositions and methods for prognosing and treating colorectal cancer
|
|
WO2018118786A1
(en)
|
2016-12-19 |
2018-06-28 |
Ventana Medical Systems, Inc. |
Methods and systems for quantitative immunohistochemistry
|
|
EP3554556B1
(de)
|
2016-12-19 |
2022-03-09 |
Ventana Medical Systems, Inc. |
Peptid-nukleinsäure-konjugate
|
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
|
WO2018146239A1
(en)
|
2017-02-10 |
2018-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
|
WO2018162404A1
(en)
|
2017-03-06 |
2018-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
|
WO2018172540A1
(en)
|
2017-03-24 |
2018-09-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to predict the progression of alzheimer's disease
|
|
WO2018189215A1
(en)
|
2017-04-12 |
2018-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from hepatocellular carcinoma
|
|
WO2018209178A1
(en)
|
2017-05-11 |
2018-11-15 |
The Research Foundation For The State University Of New York |
Method and kit for determining the presence of monosodium urate crystals in joint synovial fluid
|
|
CN107189988B
(zh)
*
|
2017-07-17 |
2019-08-30 |
江南大学 |
一株分泌抗丁香酚单克隆抗体的杂交瘤细胞株cs12及其应用
|
|
EP3659110A1
(de)
|
2017-07-24 |
2020-06-03 |
Ventana Medical Systems, Inc. |
Verfahren und systeme zur auswertung eines immunzelleninfiltrats in tumorproben
|
|
WO2019038219A1
(en)
|
2017-08-21 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
WO2019043138A1
(en)
|
2017-09-01 |
2019-03-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHOD FOR PREDICTING OUTCOME OF CANCER
|
|
EP3692368A1
(de)
|
2017-09-25 |
2020-08-12 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Verwendung von vnn1 als biomarker und therapeutisches target bei sarkomen
|
|
JP7727385B2
(ja)
|
2017-12-18 |
2025-08-21 |
ヴェンタナ メディカル システムズ, インク. |
ペプチド核酸コンジュゲート
|
|
ES2965647T3
(es)
|
2018-01-31 |
2024-04-16 |
Ventana Med Syst Inc |
Procedimientos y sistemas para la evaluación de infiltrado de células inmunitarias en cáncer colorrectal en estadio III
|
|
WO2019207030A1
(en)
|
2018-04-26 |
2019-10-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer
|
|
EP3797296B1
(de)
|
2018-05-21 |
2024-09-04 |
Genentech, Inc. |
Her2 heterogenität als ein biomarker bei krebs
|
|
WO2020016266A1
(en)
|
2018-07-17 |
2020-01-23 |
Ventana Medical Systems, Inc. |
Materials and methods for detecting fusion proteins
|
|
WO2020053376A1
(en)
|
2018-09-13 |
2020-03-19 |
Ventana Medical Systems, Inc. |
Histochemical and cytochemical methods for detecting ntrk fusion proteins
|
|
CN112789684B
(zh)
|
2018-10-01 |
2025-05-09 |
文塔纳医疗系统公司 |
用于预测对pd-1轴导向疗法的应答的方法和系统
|
|
WO2020089432A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
WO2020089428A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
|
CN113348356A
(zh)
|
2018-11-20 |
2021-09-03 |
文塔纳医疗系统公司 |
用于针对形态学特征和生物标志物表达而制备和分析细胞样品的方法和系统
|
|
CN113574386A
(zh)
|
2019-01-03 |
2021-10-29 |
国家医疗保健研究所 |
用于增强癌症患者的cd8+t细胞依赖性免疫应答的方法和药物组合物
|
|
JP2022522265A
(ja)
|
2019-01-16 |
2022-04-15 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
エリスロフェロンの変異体及びその使用
|
|
WO2020161125A1
(en)
|
2019-02-05 |
2020-08-13 |
Ventana Medical Systems, Inc. |
Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
|
|
EP3924520A1
(de)
|
2019-02-13 |
2021-12-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und zusammensetzungen zur behandlung von krebs bei einer krebskranken person
|
|
WO2020182932A1
(en)
|
2019-03-13 |
2020-09-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
|
WO2020193740A1
(en)
|
2019-03-28 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
|
EP3947737A2
(de)
|
2019-04-02 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur vorhersage und vorbeugung von krebs bei patienten mit prämalignen läsionen
|
|
JP2022530390A
(ja)
|
2019-04-24 |
2022-06-29 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗精神病剤の応答を予測するための方法
|
|
WO2020229521A1
(en)
|
2019-05-14 |
2020-11-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for inhibiting or reducing bacterial biofilms on a surface
|
|
WO2021001539A1
(en)
|
2019-07-04 |
2021-01-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy to detect and treat eosinophilic fasciitis
|
|
EP4025712A1
(de)
|
2019-09-05 |
2022-07-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren zur behandlung und prognose akuter myeloischer leukämie
|
|
WO2021074391A1
(en)
|
2019-10-17 |
2021-04-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
|
EP4110823A1
(de)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Gegen mage-a3-peptid-mhc-komplexe gerichtete polypeptide und verfahren zu deren verwendung
|
|
WO2021170777A1
(en)
|
2020-02-28 |
2021-09-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
|
WO2021186014A1
(en)
|
2020-03-20 |
2021-09-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from a cancer
|
|
WO2021224293A1
(en)
|
2020-05-07 |
2021-11-11 |
Ventana Medical Systems, Inc. |
Histochemical systems and methods for evaluating egfr and egfr ligand expression in tumor samples
|
|
EP4165214A1
(de)
|
2020-06-10 |
2023-04-19 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren zur behandlung und prognose von krebs wie glioblastom
|
|
WO2021255204A1
(en)
|
2020-06-18 |
2021-12-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
|
WO2022018163A1
(en)
|
2020-07-22 |
2022-01-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting survival time in patients suffering from cancer
|
|
WO2022063787A1
(en)
|
2020-09-22 |
2022-03-31 |
Roche Diagnostics Gmbh |
Antibodies specific for alpha-1,6-core-fucosylated psa and fucosylated fragments thereof
|
|
WO2022064049A1
(en)
|
2020-09-28 |
2022-03-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing brucella infection
|
|
EP4232603A1
(de)
|
2020-10-20 |
2023-08-30 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren zur vorhersage der reaktion auf tnf-inhibitoren
|
|
JP2023548421A
(ja)
|
2020-11-06 |
2023-11-16 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
多のう胞性卵巣症候群(pcos)を診断および処置するための方法
|
|
WO2022136252A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
|
WO2022135753A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
|
WO2022171611A1
(en)
|
2021-02-09 |
2022-08-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to pronostic lung cancer
|
|
US20240159760A1
(en)
|
2021-03-17 |
2024-05-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing pancreatic cancer
|
|
WO2022207566A1
(en)
|
2021-03-29 |
2022-10-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to evaluate pancreatic cancer prognosis
|
|
EP4326903A1
(de)
|
2021-04-23 |
2024-02-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Verfahren und zusammensetzungen zur behandlung von krankheiten im zusammenhang mit zellalterungsansammlung
|
|
WO2023280790A1
(en)
|
2021-07-05 |
2023-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
|
WO2023089159A1
(en)
|
2021-11-22 |
2023-05-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy targeting stroma/tumor cell crosstalk to treat a cancer
|
|
WO2023144303A1
(en)
|
2022-01-31 |
2023-08-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
|
WO2023152133A1
(en)
|
2022-02-08 |
2023-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing colorectal cancer
|
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
|
WO2024115935A1
(en)
|
2022-11-29 |
2024-06-06 |
Inserm |
Methods for the treatment of b-cell lymphoma using cd39 inhibitors
|
|
WO2024236131A1
(en)
|
2023-05-17 |
2024-11-21 |
Institut National de la Santé et de la Recherche Médicale |
Stratificate and method to treat a patient suffering from a cancer
|
|
WO2024245951A1
(en)
|
2023-05-26 |
2024-12-05 |
Institut National de la Santé et de la Recherche Médicale |
Combination of slc8a1 inhibitor and mitochondria-targeted antioxidant for treating melanoma
|
|
WO2025027127A1
(en)
|
2023-08-02 |
2025-02-06 |
Institut National de la Santé et de la Recherche Médicale |
New prognostic method of kidney failure
|
|
WO2025045894A1
(en)
|
2023-08-28 |
2025-03-06 |
Institut National de la Santé et de la Recherche Médicale |
Methods and kits for diagnosing cause of nephrotic syndrome and guiding therapy
|
|
WO2025068340A1
(en)
|
2023-09-27 |
2025-04-03 |
Institut National de la Santé et de la Recherche Médicale |
Method to predict aml outcome
|
|
WO2025073765A1
(en)
|
2023-10-03 |
2025-04-10 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from melanoma
|
|
WO2025078632A1
(en)
|
2023-10-12 |
2025-04-17 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from cancer
|
|
WO2025109147A1
(en)
|
2023-11-24 |
2025-05-30 |
Institut National de la Santé et de la Recherche Médicale |
Method to predict the risk of a cardiovascular event in a patient with type 2 diabetes
|
|
WO2025114473A1
(en)
|
2023-11-29 |
2025-06-05 |
Institut National de la Santé et de la Recherche Médicale |
Method for assessing diseases associated with a loss of p53 function in subjects in need thereof
|
|
WO2026013153A1
(en)
|
2024-07-10 |
2026-01-15 |
Institut National de la Santé et de la Recherche Médicale |
Methods of prognosis and treatment of patients suffering from myc-high tumors
|